Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Bohn

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concernD Aguiar Bujanda, M A Cabrera Suárez, U Bohn Sarmiento, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 27, 2007
Primary duodenal follicular lymphoma successfully treated with rituximabD Aguiar-Bujanda, I Quiñones-Morales, R Camacho-Galán, et al.
Medical Oncology (Northwood, London, England)|April 1, 2003
Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancerJ Cassinello, P López-Alvarez, A Martínez-Guisado, et al.
ESMO Open|July 30, 2021
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)J A Perez-Fidalgo, A Cortés, E Guerra, et al.
British Journal of Cancer|June 20, 2014
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX studyJ Feliu, A Salud, M J Safont, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trialEstela Pineda, A Salud, E Vila-Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2024
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyM Martín, S R Stecklein, O Gluz, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concernD Aguiar Bujanda, M A Cabrera Suárez, U Bohn Sarmiento, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 27, 2007
Primary duodenal follicular lymphoma successfully treated with rituximabD Aguiar-Bujanda, I Quiñones-Morales, R Camacho-Galán, et al.
Medical Oncology (Northwood, London, England)|April 1, 2003
Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancerJ Cassinello, P López-Alvarez, A Martínez-Guisado, et al.
ESMO Open|July 30, 2021
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)J A Perez-Fidalgo, A Cortés, E Guerra, et al.
British Journal of Cancer|June 20, 2014
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX studyJ Feliu, A Salud, M J Safont, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trialEstela Pineda, A Salud, E Vila-Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2024
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyM Martín, S R Stecklein, O Gluz, et al.
Pageof 2